Do concomitant ascites influence the effectiveness of palliative surgical management of pleural effusion in patients with malignancies?

World Journal of Surgery

Volumn 33, Issue 2, 2009, Pages 266-271

  Gross, Jefferson Luiz ^a   Disanzio, Tatiana Guilherme ^a   Younes, Riad Naim ^a   Haddad, Fabio José ^a   Da Silva, Rodrigo Afonso ^a   Avertano, Antonio Bomfim Marçal ^a  

^a A C CAMARGO CANCER CENTER   (Brazil)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ARTICLE; ASCITES; BREAST CANCER; CLINICAL ARTICLE; CLINICAL ASSESSMENT; CLINICAL EFFECTIVENESS; CONTROLLED STUDY; FEMALE; HUMAN; MALE; OVARY CANCER; PALLIATIVE THERAPY; PLEURA EFFUSION; PLEURODESIS; RECURRENT DISEASE; RETROSPECTIVE STUDY; SOLID TUMOR; SURVIVAL RATE; THORACOCENTESIS; TUBE;

ADULT; AGED; ASCITES; CHI-SQUARE DISTRIBUTION; FEMALE; HUMANS; MALE; MIDDLE AGED; PALLIATIVE CARE; PLEURAL EFFUSION, MALIGNANT; RETROSPECTIVE STUDIES; STATISTICS, NONPARAMETRIC; TREATMENT OUTCOME;

EID: 58149469552     PISSN: 03642313     EISSN: 14322323     Source Type: Journal    
DOI: 10.1007/s00268-008-9839-7     Document Type: Article

References (28)

1. AM Covey 2005 Management of malignant pleural effusions and ascites Support Oncol 3 2 169 176
2. MM DeCamp SJ Mentzer SJ Swanson 1999 Malignant effusive disease of the pleura and pericardium Chest 112 291S 295S
3. JR Mackey PM Venner 1996 Malignant ascites: demographics, therapeutic efficacy and predictors of survival Can J Oncol 6 474 480
4. AA Ayantunde SL Parsons 2007 Pattern and prognostic factors in patients with malignant ascites: a retrospective study Ann Oncol 18 5 945 949
5. AR Gasparri F Leo G Veronesi 2006 Video-assisted management of malignant pleural effusion in breast carcinoma Cancer 106 2 271 276
6. FJ Haddad RN Younes JL Gross 2004 Pleurodesis in patients with malignant pleural effusions: talc slurry or bleomycin? Results of a prospective randomized trial World J Surg 28 8 749 753 discussion 753-754
7. PW Zimmer M Hill K Casey 1997 Prospective randomized trial of talc slurry vs bleomycin in pleurodesis for symptomatic malignant pleural effusions Chest 112 2 430 434
8. L Kennedy VW Rusch C Strange 1994 Pleurodesis using talc slurry Chest 106 2 342 346
9. Stefani A, Natali P, Casali C et al (2006) Talc poudrage versus talc slurry in the treatment of malignant pleural effusion. A prospective comparative study. Eur J Cardiothorac Surg 30(6):827-832
10. I Hunt E Teh R Southon 2007 Using non-steroidal anti-inflammatory drugs (NSAIDs) following pleurodesis Interact Cardiovasc Thorac Surg 6 1 102 104
11. JE Heffner JN Heffner LK Brown 2003 Multilevel and continuous pleural fluid pH likelihood ratios for evaluating malignant pleural effusions Chest 123 6 1887 1894
12. CM Burrows WC Mathews HG Colt 2000 Predicting survival in patients with recurrent symptomatic malignant pleural effusions: an assessment of the prognostic values of physiologic, morphologic, and quality of life measures of extent of disease Chest 117 1 73 78
13. A Crnjac M Sok M Kamenik 2004 Impact of pleural effusion pH on the efficacy of thoracoscopic mechanical pleurodesis in patients with breast carcinoma Eur J Cardiothorac Surg 26 2 432 436
14. S Yamada T Takeda K Matsumoto 1983 Prognostic analysis of malignant pleural and peritoneal effusions Cancer 51 136 140
15. EM Marom JJ Erasmus JE Herndon II 2002 Usefulness of imaging-guided catheter drainage and talc sclerotherapy in patients with metastatic gynecologic malignancies and symptomatic pleural effusions AJR Am J Roentgenol 179 1 105 108
16. A Emad GR Rezaian 1998 Closed percutaneous pleural brushing: a new method for diagnosis of malignant pleural effusions Respir Med 92 4 659 663
17. JE Heffner JS Klein 2008 Recent advances in the diagnosis and management of malignant pleural effusions Mayo Clin Proc 83 2 235 250
18. V Steger U Mika H Toomes 2007 Who gains most? A 10-year experience with 611 thoracoscopic talc pleurodeses Ann Thorac Surg 83 6 1940 1945
19. JP Janssen G Collier P Astoul 2007 Safety of pleurodesis with talc poudrage in malignant pleural effusion: a prospective cohort study Lancet 369 9572 1535 1539
20. C Tan A Sedrakyan J Browne 2006 The evidence on the effectiveness of management for malignant pleural effusion: a systematic review Eur J Cardiothorac Surg 29 5 829 838
21. S Kolschmann A Ballin A Gillissen 2005 Clinical efficacy and safety of thoracoscopic talc pleurodesis in malignant pleural effusions Chest 128 3 1431 1435
22. SA Sahn 2001 Malignant pleural effusions Semin Respir Crit Care Med 22 6 607 616
23. S Wilailak V Linasmita S Srivannaboon 1999 Malignant ascites in female patients: a seven year review J Med Assoc Thai 82 15
24. LJ Herrinton C Neslund-Dudas SJ Rolnick 2007 Complications at the end of life in ovarian cancer J Pain Symptom Manage 34 3 237 243
25. V Gushchin TL Demmy JM Kane III 2007 Surgical management of metastatic peritoneal or pleural disease Semin Oncol 34 3 215 225
26. G Becker D Galandi HE Blum 2006 Malignant ascites: systematic review and guideline for treatment Eur J Cancer 42 5 589 597
27. FJ van de Molengraft GP Vooijs 1988 The interval between the diagnosis of malignancy and the development of effusions, with reference to the role of cytologic diagnosis Acta Cytol 32 2 183 187
28. RD Rubens 2001 Management of advanced breast cancer Int J Clin Pract 55 676 679